Hanson & Doremus Investment Management Raises Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)
Hanson & Doremus Investment Management boosted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 9.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 916 shares of the medical research company’s stock after acquiring an additional 80 shares during the period. Hanson & Doremus […]
More Stories
Insider Buying: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Director Purchases $181,100.00 in Stock
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) Director Michael R. Hayden purchased 5,000 shares of the company’s stock in...
Insider Buying: Benitec Biopharma Inc. (NASDAQ:BNTC) Director Acquires $301,971.96 in Stock
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) Director Suvretta Capital Management, L bought 27,502 shares of the business’s stock...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Sells $244,842.48 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 2,104 shares of the stock in a transaction...
Brokerages Set First Citizens BancShares, Inc. (NASDAQ:FCNCA) PT at $2,243.64
First Citizens BancShares, Inc. (NASDAQ:FCNCA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve...
Matador Resources (NYSE:MTDR) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Matador Resources (NYSE:MTDR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the...
R David Schmaier Sells 1,785 Shares of Salesforce, Inc. (NYSE:CRM) Stock
Salesforce, Inc. (NYSE:CRM – Get Free Report) insider R David Schmaier sold 1,785 shares of the business’s stock in a...